2016-03-08T00:00:00.000-05:00
clinical pipeline,0.22019
publicly traded company,-0.242488
clinical-stage biopharmaceutical company,0.249797
one-time license fee,-0.250747
candidate development activities,0.314768
recent periodic reports,-0.318682
best-in-class therapies,-0.325237
clinical trials,0.29998
financial goals,0.649434
corresponding period,-0.202759
license fee liability,-0.250747
net loss,-0.358192
forward-looking statements,-0.389468
initial public offering,-0.242488
